SEC Form 8-K Summary
Registrant: Deep Medicine Acquisition Corp. (metadata identifies Trugolf Holdings, Inc., which does not match the filing text).
Reporting date: November 30, 2021. The filing reports a securities-trading change under Item 8.01 and provides an associated press release as Exhibit 99.1.
Business Context and Reporting Period
Deep Medicine Acquisition Corp. was a special purpose acquisition company incorporated in Delaware and listed on Nasdaq. The filing does not provide operating-business or financial-period information.
Key Financial Metrics
- Revenue, profit, cash flow, margins, debt, liquidity, assets, and liabilities: the filing text does not provide clear values.
- No financial statements or financial guidance are included in the filing text.
Material Change and Trading Update
- Beginning December 2, 2021, the company’s units were scheduled to cease trading.
- The Class A common stock and rights comprising the units were scheduled to begin trading separately.
- The separation was described as mandatory and automatic; unit holders were not required to take action.
- The filing states that the securities would trade on Nasdaq under the symbols DMAQ for Class A common stock and DMAQR for rights. The text also refers to “warrants” in one sentence, creating a terminology inconsistency that should be verified against the attached press release and Nasdaq listing.
Outlook, Risks, and Unusual Items
The filing provides no business outlook, earnings guidance, management forecast, contingencies, or material risk discussion. The principal disclosed event is the automatic separation of the company’s units into separately traded securities.
Important Facts to Verify
- Confirm the correct registrant: the filing names Deep Medicine Acquisition Corp., not Trugolf Holdings, Inc.
- Verify whether DMAQR represents rights or warrants, given the inconsistent terminology in the filing text.
- Confirm the December 2, 2021 effective trading date and the applicable Nasdaq market designation.
- Review Exhibit 99.1 for the complete details of the securities separation.